Plump Andrew Stewart — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Plump Andrew Stewart has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Plump Andrew Stewart

Andrew Stewart Plump is a prominent executive in the pharmaceutical industry, currently serving as the President of Research and Development at Takeda Pharmaceutical Company Limited. He has a strong background in drug development and has contributed significantly to the advancement of various therapeutic areas within the company. Plump's leadership in R&D has been pivotal in driving innovation and enhancing the company's pipeline.

RolePresident, R&D, Director
Notability75/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-06TAKTAKEDA PHARMACEUTICAL CO LTDA — Grant or award125.4K$0.00
2026-04-28TAKTAKEDA PHARMACEUTICAL CO LTDA — Grant or award212.5K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Plump Andrew Stewart?

Andrew Stewart Plump is a prominent executive in the pharmaceutical industry, currently serving as the President of Research and Development at Takeda Pharmaceutical Company Limited. He has a strong background in drug development and has contributed significantly to the advancement of various therapeutic areas within the company. Plump's leadership in R&D has been pivotal in dr…

How many SEC Form 4 filings has Plump Andrew Stewart submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Plump Andrew Stewart's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Plump Andrew Stewart profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.